Balyasny Asset Management LLC Neuronetics, Inc. Transaction History
Balyasny Asset Management LLC
- $54.9 Billion
- Q2 2024
A detailed history of Balyasny Asset Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,144,232 shares of STIM stock, worth $858,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,144,232
Previous 1,169,505
2.16%
Holding current value
$858,174
Previous $5.57 Million
63.01%
% of portfolio
0.0%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding STIM
# of Institutions
68Shares Held
18.3MCall Options Held
0Put Options Held
3.8K-
Archon Capital Management LLC Seattle, WA2.47MShares$1.85 Million3.67% of portfolio
-
Cannell Capital LLC Alta, WY2.38MShares$1.79 Million1.07% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$1.3 Million1.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$974,9360.0% of portfolio
-
First Washington Corp Seattle, WA1.27MShares$955,9050.89% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $20.3M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...